These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6431988)

  • 1. Inactivation of microsomal NADPH-cytochrome c reductase by sulfhydryl-reactive derivatives of menadione.
    Talcott RE; Ketterman A; Giannini DG
    Biochem Pharmacol; 1984 Aug; 33(16):2663-8. PubMed ID: 6431988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition studies on the involvement of flavoprotein reductases in menadione- and nitrofurantoin-stimulated oxyradical production by hepatic microsomes of flounder (Platichthys flesus).
    Lemaire P; Livingstone DR
    J Biochem Toxicol; 1994 Apr; 9(2):87-95. PubMed ID: 8071949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inactivation of rat lung and liver microsomal NADPH-cytochrome c reductase by acrolein.
    Patel JM; Ortiz E; Kolmstetter C; Leibman KC
    Drug Metab Dispos; 1984; 12(4):460-3. PubMed ID: 6148213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of essential carboxyl group for binding of cytochrome c in rat hepatic NADPH-cytochrome P-450 reductase by the reaction with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
    Inano H; Tamaoki B
    J Enzyme Inhib; 1985; 1(1):47-59. PubMed ID: 2854844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the microsomal electron-transport system of anaerobically grown yeast. V. Purification and characterization of NADPH-cytochrome c reductase.
    Kubota S; Yoshida Y; Kumaoka H; Furumichi A
    J Biochem; 1977 Jan; 81(1):197-205. PubMed ID: 14931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible modification of cysteine residues of NADPH-cytochrome P-450 reductase.
    Yelinova VI; Weiner LM; Slepneva IA; Levina AS
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1044-8. PubMed ID: 8391797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of microsomal cytochrome c reductase activity by a series of alpha, beta-unsaturated aldehydes.
    Cooper KO; Witmer CM; Witz G
    Biochem Pharmacol; 1987 Mar; 36(5):627-31. PubMed ID: 3103627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of one-electron reduction of quinones by microsomal flavin enzymes: the kinetic analysis between cytochrome B5 and menadione.
    Iyanagi T
    Free Radic Res Commun; 1990; 8(4-6):259-68. PubMed ID: 2113027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K3-dependent NADPH oxidase of liver microsomes. Purification, properties, and identity with microsomal NADPH-cytochrome c reductase.
    Nishibayashi-Yamashita H; Sato R
    J Biochem; 1970 Feb; 67(2):199-210. PubMed ID: 4392646
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphatase affects microsomal monooxygenase mainly via reductase.
    Pyerin W; Jochum C; Taniguchi H; Wolf CR
    Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):133-6. PubMed ID: 3092291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH-cytochrome P-450 reductase is not a component of the liver microsomal steroid 5-alpha reductase.
    Cheng KC; Wang RW; Lu AY
    Biochem Biophys Res Commun; 1989 Dec; 165(2):590-4. PubMed ID: 2512918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by ebselen of microsomal NADPH-cytochrome P450-reductase in vitro but not in vivo.
    Wendel A; Otter R; Tiegs G
    Biochem Pharmacol; 1986 Sep; 35(18):2995-7. PubMed ID: 3092829
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-dependent changes in rat liver microsomal NADPH cytochrome C (P-450) reductase: a kinetic analysis.
    Schmucker DL; Wang RK
    Exp Gerontol; 1983; 18(4):313-21. PubMed ID: 6321214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of rat testicular NADPH-cytochrome P-450 reductase by 2,4,6-trinitrobenzenesulfonate.
    Inano H; Kurihara S; Tamaoki B
    J Steroid Biochem; 1988 Feb; 29(2):227-32. PubMed ID: 3126367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of phosphatase on the components of the cytochrome P-450-dependent microsomal monooxygenase.
    Taniguchi H; Pyerin W
    Biochim Biophys Acta; 1987 Apr; 912(3):295-302. PubMed ID: 3105584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the reduction of oxygen, artificial acceptors and cytochrome P-450 by NADPH--cytochrome c reductase.
    Lyakhovich V; Mishin V; Pokrovsky A
    Biochem J; 1977 Nov; 168(2):133-9. PubMed ID: 202259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible inhibition of NADPH-cytochrome P450 reductase by alpha-lipoic acid.
    Slepneva IA; Sergeeva SV; Khramtsov VV
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1246-53. PubMed ID: 7575537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
    Zbaida S; Levine WG
    Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH-cytochrome P-450 reductase: preferential inhibition by ellipticine and other type II compounds having little effect on NADPH-cytochrome c reductase.
    Guenthner TM; Kahl GF; Nebert DW
    Biochem Pharmacol; 1980 Jan; 29(1):89-95. PubMed ID: 6767479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.